Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib and Paclitaxel in HER2+ Advanced Gastric/GEJ/Esophageal Cancer
NCT02274012Phase 2Withdrawn
- Sponsor
- Columbia University
- Start
- May 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of afatinib in gastric cancer (GC), gastroesophageal junction cancer, esophageal cancer, sponsored by Columbia University. Planned start May 2014; status: withdrawn.
02
Drugs
afatinib
03
Conditions
gastric cancer (GC)gastroesophageal junction canceresophageal cancer
Beyond the preview
Go deeper on NCT02274012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02274012.